Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Michael Garone


  • Interim Cfo at Adaptimmune Therapeutics Plc (ADAP), 2019-10-02
  • Chief Financial Officer at Immunomedics Inc (IMMU), 2017-07-06
  • Cfo at Emisphere Technologies Inc (EMIS), 2016-04-11
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EMIS $1.08 60,000 Officer 100,000 2010-09-17 Filing
EMIS $1.07 5,000 Officer 40,000 2010-09-15 Filing
EMIS $1.08 500 Officer 35,000 2010-09-15 Filing
EMIS $1.08 2,500 Officer 34,500 2010-09-15 Filing
EMIS $1.10 32,000 Officer 32,000 2010-09-15 Filing